Topic · 06 of 08

Business & Finance

607 Articles in this topic

All607 stories in Business & Finance

Newest first
News, Society & Economy

OpenAI to Offer 'GPT-5.5 Cyber' to Japanese Government: Why Nakasone Flew to Tokyo, and What It Means for the Anthropic 'Mythos' Race

OpenAI is moving to offer its newest cyber-focused AI model, GPT-5.5 Cyber, to the Japanese government and industry. Former NSA Director Paul Nakasone, now an OpenAI board member, flew to Tokyo to pitch critical-infrastructure cooperation. We unpack the contrast with Anthropic's tightly controlled Claude Mythos, the China-threat framing, and what it means that OpenAI wants Japan as its first international partner.

Tech & Science

Japan's First 100% Hydrogen Power Plant: UK-Backed Hoku Energy Wins National Auction for 106.6MW Aomori Project

Hoku Energy K.K., the Japanese subsidiary of UK-based Hoku Infrastructure, will build Japan's first new-build 100% hydrogen mono-firing thermal power plant in Aomori Prefecture. The 106.6MW Daiichi Plant, awarded under Japan's 3rd Long-Term Decarbonized Power Source Auction, is scheduled to start operations in the early-to-mid 2030s. We compare it with hydrogen power efforts by Plug Power, MHI in Utah, Linde, Air Liquide, and South Korea's Doosan, and explain what it means for Japan's GX strategy.

Tech & Science

Japan's Tooth-Regrowing Drug Heads to Pediatric Trials This Summer — Kyoto Spinoff Raises $5.3M for World-First Antibody

Kyoto University spinoff Toregem Biopharma kicks off Phase 2 trials this summer for TRG035, the world's first regenerative tooth drug, after raising an additional ¥850 million ($5.3M). Twenty-four pediatric patients with severe congenital tooth agenesis will receive the antibody. Here is what the deal tells us about Japan's deep-tech biotech funding stack — and how a super-aging society is becoming a uniquely positioned market for medical innovation.